Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial-Reference-Cited by-同舟云学术

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

Published:2012-03 Issue:3 Volume:13 Page:275-284
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cheung Angela M,Tile Lianne,Cardew Savannah,Pruthi Sandhya,Robbins John,Tomlinson George,Kapral Moira K,Khosla Sundeep,Majumdar Sharmila,Erlandson Marta,Scher Judy,Hu Hanxian,Demaras Alice,Lickley Lavina,Bordeleau Louise,Elser Christine,Ingle James,Richardson Harriet,Goss Paul E

Publisher

Elsevier BV

Subject

Oncology

Reference44 articles.

1. Global cancer statistics;Jemal;CA: Cancer J Clin,2011

2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

3. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up;Regan;Lancet Oncol,2011

4. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Eng J Med,2004

5. Exemestane for breast-cancer prevention in postmenopausal women;Goss;N Eng J Med,2011

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroidogenic cytochrome P450 enzymes as drug target;Toxicological Research;2024-04-22

2. Epidemiology of Osteoporosis;Endocrinology;2023-12-09

3. Targeting nuclear hormone receptors for the prevention of breast cancer;Frontiers in Medicine;2023-07-31

4. Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience;Bone Reports;2022-06

5. Breast Cancer Risk Assessment and Management of the High-Risk Patient;Obstetrics and Gynecology Clinics of North America;2022-03